Журнал «Современная Наука»

Russian (CIS)English (United Kingdom)
MOSCOW +7(495)-142-86-81

Application azilsartan medoxomil (edarbi) in hypertension

Ataeva Zulmira Narimanovna  (candidate of Medical Sciences, Associate Professor of the Dagestan State Medical University, Makhachkala)

Kudaev Magomed Tagirovich  (professor, Dagestan State Medical University, Makhachkala)

Shamilova Sаbina Gadzhimagomedovna  (аssistant of the Dagestan State Medical University, Makhachkala)

Gadzhieva Tutubicha Abdurakhmanovna  (professor of the Dagestan State Medical University, Makhachkala)

The study involved 60 patients with arterial hypertension I-II degree, which was accepted in 12 weeks – azilsartan medoxomil. Before and after treatment were assessed indicators of body mass index, heart rate, blood pressure, lipid profile, blood glucose, index, Sokolov-Lyons, indicators of Echocardiography, ABPM, the level of anxiety, quality of life and adherence to therapy. In the course of treatment was observed a significant decrease of blood pressure, blood glucose, level of anxiety on a scale of Hamilton and the improvement of the ABPM parameters, the quality of life of patients.

Keywords:arterial hypertension, factors, risk, diseases, organ systems, clinical condition.

 

Read the full article …



Citation link:
Ataeva Z. N., Kudaev M. T., Shamilova S. G., Gadzhieva T. A. Application azilsartan medoxomil (edarbi) in hypertension // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2018. -№01. -С. 72-75
LEGAL INFORMATION:
Reproduction of materials is permitted only for non-commercial purposes with reference to the original publication. Protected by the laws of the Russian Federation. Any violations of the law are prosecuted.
© ООО "Научные технологии"